Filing Details
- Accession Number:
- 0001325812-16-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-21 17:01:49
- Reporting Period:
- 2016-04-19
- Filing Date:
- 2016-04-21
- Accepted Time:
- 2016-04-21 17:01:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1180432 | John Maraganore | 300 Third Street Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-19 | 15,076 | $22.75 | 148,465 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-19 | 9,371 | $67.02 | 139,094 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-04-19 | 5,405 | $68.00 | 133,689 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-04-19 | 300 | $68.71 | 133,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-04-20 | 15,075 | $22.75 | 148,464 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-20 | 12,670 | $67.38 | 135,794 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-04-20 | 2,405 | $68.24 | 133,389 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2016-04-19 | 15,076 | $0.00 | 15,076 | $22.75 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2016-04-20 | 15,075 | $0.00 | 15,075 | $22.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,377 | 2016-12-14 | No | 4 | M | Direct | |
| 60,302 | 2016-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,750 | Indirect | by Managed Account |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2015. The 30,151 options exercised and sold by the reporting person were due to expire on December 14, 2016.
- Sale prices ranged from $66.58 to $67.55.
- Sale prices ranged from $67.58 to $68.41.
- Sale prices ranged from $68.61 to $68.88.
- Sale prices ranged from $66.95 to $67.94.
- Sale prices ranged from $67.96 to $68.95.
- The reporting person owns 2,750 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter
Billionaire Hedge Funds
